• 3952 Citations
  • 22 Scopus h-Index
20072019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Wen Wee Ma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
gemcitabine Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Survival Medicine & Life Sciences
irinotecan Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2007 2019

Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort

Sanhueza, C. T., Huffman, B. M., Jin, Z., Hartgers, M. L., Smyrk, T. C., Westin, G., Mc Williams, R. R., Ma, W. W., Alberts, S. R. & Mahipal, A., Apr 1 2019, In : Pancreas. 48, 4, p. E21-E22

Research output: Contribution to journalLetter

Pancreatic Neoplasms

Survival and prognostic factors in patients with pancreatic squamous cell carcinoma

Tella, S. H., Kommalapati, A., Yadav, S., Bergquist, J. R., Truty, M., Durgin, L., Ma, W. W., Cleary, S. P., Mc Williams, R. R. & Mahipal, A., Jan 1 2019, In : European Journal of Surgical Oncology.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Survival
Neoplasms
Drug Therapy
Survival Analysis
7 Citations (Scopus)

A multicenter phase II study of gemcitabine, capecitabine, and bevacizumab for locally advanced or metastatic biliary tract cancer

Iyer, R. V., Pokuri, V. K., Groman, A., Ma, W. W., Malhotra, U., Iancu, D. M., Grande, C. & Bekaii-Saab, T., Jul 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 7, p. 649-655 7 p.

Research output: Contribution to journalArticle

gemcitabine
Biliary Tract Neoplasms
Circulating Neoplastic Cells
Survival
Vascular Endothelial Growth Factor A
2 Citations (Scopus)

A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma

Cohen, S. J., Zalupski, M. M., Conkling, P., Nugent, F., Ma, W. W., Modiano, M., Pascual, R., Lee, F. C., Wong, L. & Hersh, E., Jan 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 230-235 6 p.

Research output: Contribution to journalArticle

gemcitabine
Multicenter Studies
Adenocarcinoma
Placebos
Drug Therapy
1 Citation (Scopus)

A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib with Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients

Ma, W. W., Xie, H., Fetterly, G., Pitzonka, L., Whitworth, A., Levea, C., Wilton, J., Mantione, K., Schihl, S., Dy, G. K., Boland, P., Iyer, R., Tan, W., Brady, W., Straubinger, R. M. & Adjei, A., Jan 1 2018, (Accepted/In press) In : American Journal of Clinical Oncology: Cancer Clinical Trials.

Research output: Contribution to journalArticle

gemcitabine
Pancreatic Neoplasms
Maximum Tolerated Dose
Neoplasms
Biliary Tract Neoplasms